Arcutis Biotherapeutics, Inc. (ARQT)

29.87 +0.29 (+0.98%) USD  |  NASDAQ  |  Jan 08, 16:00
29.84 -0.03 (-0.10%) After-Hours: 19:49
More

Arcutis Biotherapeutics Research and Development Expense (Annual): 76.42M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for ARQT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
CorMedix, Inc. 3.942M
ADMA Biologics, Inc. 1.813M
ANI Pharmaceuticals, Inc. 44.58M
Editas Medicine, Inc. 193.44M
Amicus Therapeutics, Inc. 109.36M